Nucleophosmin 1 cooperates with the methyltransferase DOT1L to preserve peri-nucleolar heterochromatin organization by regulating H3K27me3 levels and DNA repeats expression.
DOT1L
Epigenetics
Histone methylation
NPM1
Peri-nucleolar heterochromatin
Transcription
Journal
Epigenetics & chromatin
ISSN: 1756-8935
Titre abrégé: Epigenetics Chromatin
Pays: England
ID NLM: 101471619
Informations de publication
Date de publication:
28 Sep 2023
28 Sep 2023
Historique:
received:
27
03
2023
accepted:
21
09
2023
medline:
27
11
2023
pubmed:
28
9
2023
entrez:
27
9
2023
Statut:
epublish
Résumé
NPM1 is a phosphoprotein highly abundant in the nucleolus. However, additional nuclear functions have been attributed to NPM1, probably through interaction with other nuclear factors. DOT1L is one interaction partner of NPM1 that catalyzes methylation of histone H3 at lysine 79 (H3K79). DOT1L, playing functional roles in several biological processes, is known for its capability to organize and regulate chromatin. For example, DOT1L modulates DNA repeats expression within peri-nucleolar heterochromatin. NPM1 also affects peri-nucleolar heterochromatin spatial organization. However, it is unclear as of yet whether NPM1 and DOT1L functionally synergize to preserve nucleoli organization and genome stability, and generally, which molecular mechanisms would be involved. We characterized the nuclear function of NPM1 on peri-nucleolar heterochromatin organization. We show that (i) monomeric NPM1 interacts preferentially with DOT1L in the nucleus; (ii) NPM1 acts in concert with DOT1L to maintain each other's protein homeostasis; (iii) NPM1 depletion results in H3K79me2 upregulation and differential enrichment at chromatin binding genes including Ezh2; (iv) NPM1 and DOT1L modulate DNA repeats expression and peri-nucleolar heterochromatin organization via epigenetic mechanisms dependent on H3K27me3. Our findings give insights into molecular mechanisms employed by NPM1 and DOT1L to regulate heterochromatin activity and structural organization around the nucleoli and shed light on one aspect of the complex role of both proteins in chromatin dynamics.
Sections du résumé
BACKGROUND
BACKGROUND
NPM1 is a phosphoprotein highly abundant in the nucleolus. However, additional nuclear functions have been attributed to NPM1, probably through interaction with other nuclear factors. DOT1L is one interaction partner of NPM1 that catalyzes methylation of histone H3 at lysine 79 (H3K79). DOT1L, playing functional roles in several biological processes, is known for its capability to organize and regulate chromatin. For example, DOT1L modulates DNA repeats expression within peri-nucleolar heterochromatin. NPM1 also affects peri-nucleolar heterochromatin spatial organization. However, it is unclear as of yet whether NPM1 and DOT1L functionally synergize to preserve nucleoli organization and genome stability, and generally, which molecular mechanisms would be involved.
RESULTS
RESULTS
We characterized the nuclear function of NPM1 on peri-nucleolar heterochromatin organization. We show that (i) monomeric NPM1 interacts preferentially with DOT1L in the nucleus; (ii) NPM1 acts in concert with DOT1L to maintain each other's protein homeostasis; (iii) NPM1 depletion results in H3K79me2 upregulation and differential enrichment at chromatin binding genes including Ezh2; (iv) NPM1 and DOT1L modulate DNA repeats expression and peri-nucleolar heterochromatin organization via epigenetic mechanisms dependent on H3K27me3.
CONCLUSIONS
CONCLUSIONS
Our findings give insights into molecular mechanisms employed by NPM1 and DOT1L to regulate heterochromatin activity and structural organization around the nucleoli and shed light on one aspect of the complex role of both proteins in chromatin dynamics.
Identifiants
pubmed: 37759327
doi: 10.1186/s13072-023-00511-9
pii: 10.1186/s13072-023-00511-9
pmc: PMC10537513
doi:
Substances chimiques
Histones
0
Heterochromatin
0
Nucleophosmin
117896-08-9
Chromatin
0
DNA
9007-49-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
36Informations de copyright
© 2023. The Author(s).
Références
Nat Commun. 2019 Jun 26;10(1):2803
pubmed: 31243293
J Neurol Sci. 2008 Mar 15;266(1-2):131-7
pubmed: 17949752
Sci Adv. 2020 Oct 14;6(42):
pubmed: 33055158
Nat Commun. 2020 Aug 19;11(1):4153
pubmed: 32814769
PLoS One. 2011 Jan 20;6(1):e16401
pubmed: 21283722
Biochemistry. 1995 Jun 27;34(25):8037-42
pubmed: 7794916
Nucleic Acids Res. 2023 Sep 22;51(17):8970-8986
pubmed: 37522386
Mol Cell. 2001 Oct;8(4):841-53
pubmed: 11684019
Epigenetics. 2012 Aug;7(8):811-4
pubmed: 22735386
Leukemia. 2017 Apr;31(4):798-807
pubmed: 28111462
EMBO Rep. 2019 Oct 4;20(10):e48068
pubmed: 31448565
Mol Cell. 2004 Jan 30;13(2):291-8
pubmed: 14759373
Clin Epigenetics. 2019 Jan 7;11(1):4
pubmed: 30616689
Mol Biol Cell. 2002 Jun;13(6):2016-30
pubmed: 12058066
Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):
pubmed: 34187895
Theranostics. 2020 Jan 1;10(4):1758-1776
pubmed: 32042335
Genome Med. 2018 Apr 17;10(1):30
pubmed: 29665865
Innovation (Camb). 2021 Jul 01;2(3):100141
pubmed: 34557778
Nucleic Acids Res. 2019 Jan 10;47(1):168-183
pubmed: 30329130
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Cancer Cell. 2014 Dec 8;26(6):896-908
pubmed: 25464900
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):7042-7
pubmed: 20348416
Nature. 2012 Jan 04;481(7381):389-93
pubmed: 22217937
Mol Cell. 2020 May 7;78(3):459-476.e13
pubmed: 32240602
Cell. 2006 May 5;125(3):483-95
pubmed: 16603237
J Hematol Oncol. 2017 Jan 23;10(1):29
pubmed: 28114995
Genome Res. 2019 Aug;29(8):1235-1249
pubmed: 31201210
J Biol Chem. 2016 Sep 23;291(39):20787-97
pubmed: 27510036
Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4466-71
pubmed: 24616519
Int J Med Sci. 2011 Apr 20;8(4):287-94
pubmed: 21537492
Cell Death Differ. 2016 Apr;23(4):555-64
pubmed: 25526092
Mol Cell. 2003 Nov;12(5):1151-64
pubmed: 14636574
Stem Cells. 2009 Jul;27(7):1538-47
pubmed: 19544450
Sci Rep. 2018 Mar 5;8(1):4008
pubmed: 29507312
Sci Rep. 2015 May 12;5:9824
pubmed: 25965993
Nucleic Acids Res. 2016 Jul 8;44(W1):W3-W10
pubmed: 27137889
Biochem Soc Trans. 2020 Oct 30;48(5):1967-1978
pubmed: 32897323
EMBO Rep. 2023 Aug 3;24(8):e56233
pubmed: 37382163
EMBO Rep. 2021 Feb 3;22(2):e51184
pubmed: 33410591
Cancer Discov. 2023 Mar 1;13(3):724-745
pubmed: 36455589
Ther Adv Hematol. 2020 Feb 3;11:2040620719899818
pubmed: 32071709
Mol Cell. 2009 Sep 11;35(5):626-41
pubmed: 19682934
EMBO Rep. 2021 Aug 4;22(8):e52785
pubmed: 34224201
Chromosoma. 2016 Sep;125(4):593-605
pubmed: 26728620
Curr Biol. 2002 Jun 25;12(12):1052-8
pubmed: 12123582
Blood. 2011 Sep 15;118(11):3096-106
pubmed: 21719597
Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27365-27373
pubmed: 33077595
EMBO Rep. 2023 Aug 3;24(8):e56492
pubmed: 37317657
Cancer Res. 2010 Sep 1;70(17):6746-56
pubmed: 20713529
Cytogenet Genome Res. 2012;136(2):89-96
pubmed: 22286186
Oncogene. 2018 May;37(18):2351-2366
pubmed: 29429989
Epigenetics Chromatin. 2020 Oct 31;13(1):47
pubmed: 33129354
Cancer Discov. 2016 Oct;6(10):1166-1181
pubmed: 27535106
J Am Soc Nephrol. 2020 Feb;31(2):337-349
pubmed: 31843983
Biochem Res Int. 2011;2011:195209
pubmed: 21152184
Science. 2003 Apr 25;300(5619):633-6
pubmed: 12714744
Genes Dev. 2011 Jul 1;25(13):1345-58
pubmed: 21724828
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Bioinformatics. 2015 Jul 15;31(14):2382-3
pubmed: 25765347
Science. 2004 Jan 30;303(5658):672-6
pubmed: 14704433
Nat Commun. 2020 Oct 15;11(1):5200
pubmed: 33060580
Nat Commun. 2018 Feb 26;9(1):842
pubmed: 29483575
J Cell Sci. 2006 Sep 1;119(Pt 17):3676-85
pubmed: 16912078
N Engl J Med. 2005 Jan 20;352(3):254-66
pubmed: 15659725
Protein J. 2010 Apr;29(3):213-23
pubmed: 20431927
Sci Adv. 2020 Apr 17;6(16):eaaz9899
pubmed: 32494624
Nat Commun. 2022 Mar 18;13(1):1483
pubmed: 35304483
Blood. 2005 Dec 1;106(12):3747-54
pubmed: 16109776
J Biol Chem. 2012 Nov 16;287(47):39698-709
pubmed: 23012353
Theranostics. 2018 Jul 30;8(16):4359-4371
pubmed: 30214626
Cell. 1989 Feb 10;56(3):379-90
pubmed: 2914325
Nucleic Acids Res. 1998 Oct 1;26(19):4508-15
pubmed: 9742256
Mol Cell Biol. 2022 Feb 17;42(2):e0066920
pubmed: 34898280
Stem Cells. 2016 Jan;34(1):233-45
pubmed: 26299268
Stem Cell Reports. 2022 Feb 8;17(2):384-396
pubmed: 34995500
J Biol Chem. 2014 Dec 12;289(50):34601-19
pubmed: 25349213
PLoS One. 2014 Dec 09;9(12):e115062
pubmed: 25490769
J Cell Physiol. 2021 Nov;236(11):7832-7852
pubmed: 33959979
J Clin Oncol. 2013 Jan 20;31(3):e44-7
pubmed: 23248243